pmc logo image
Logo of ajhgJournal URL: http://www.cell.com/AJHG/

Formats:

Am J Hum Genet. 2006 September; 79(3): 427–428.
PMCID: PMC1559547
Introductory Speech for Patrick O. Brown*
Evan Eichler
From the Department of Genome Sciences and the Howard Hughes Medical Institute, University of Washington School of Medicine, Seattle
Address for correspondence and reprints: Dr. Evan Eichler, Department of Genome Sciences and the Howard Hughes Medical Institute, University of Washington School of Medicine, Health Sciences, K-336, 1705 NE Pacific Street, Box 357730, Seattle, WA 98195. E-mail: eee/at/gs.washington.edu
figure AJHGv79p427fg1
figure AJHGv79p427fg1
Evan Eichler
It is my honor to introduce the 2005 Curt Stern awardee, Patrick Brown, M.D., Ph.D. Established in 2001, the Curt Stern Award recognizes scientific excellence in the field of human genetics on the basis of research performed over the last 10 years. In particular, this award is given to a recipient not only as a mark of outstanding scientific achievement, but also to a researcher who has pioneered an area of research that has significantly advanced the field of human genetics. The revolutionary research of Dr. Brown in both the technological development and application of gene-based expression microarrays eminently qualifies him for this award.
Dr. Patrick Brown is a professor in the Department of Biochemistry at Stanford University School of Medicine and an Investigator of the Howard Hughes Medical Institute. He began his career in the field of chemistry, graduating with his B.A. (honors) from the University of Chicago in 1976. He then moved to the Department of Biochemistry, where he was awarded his Ph.D. on studies of DNA topoisomerases, under the mentorship of Nicholas Cozzarelli, Ph.D. After completing his M.D. and pediatric residency, he moved to the University of California–San Francisco, where he worked as a postdoctoral fellow in the laboratory of Drs. J. Michael Bishop and Harold E. Varmus. In 1988, he joined the faculty of the Department of Biochemistry, Stanford University School of Medicine, as an assistant professor and an investigator of the Howard Hughes Medical Institute.
In 1995, he was the lead investigator of two seminal publications1,2 that ushered in the era of gene-expression–microarray analysis and revolutionized molecular biology. Although this initial work focused on detailing the transcriptional program of yeast and Arabidopsis, the utility of microarray technology to understand developmental, physiological, and pathological processes in humans became apparent. The development of cDNA microarrays to interrogate the expression differences of tens of thousands of genes simultaneously represents both a technological and a conceptual advance of our field. His work to systematically characterize variation in gene expression anticipated the next logical extension of the Human Genome Project.
Consequently, Dr. Brown and his collaborators have paved the way, demonstrating the utility of gene-expression microarrays for pinpointing transcriptional differences between normal and cancer tissues,35 characterizing transcriptional differences due to stress or pharmacological agents,6 and identifying genes that distinguish development pathways of normal tissues.7,89 Due largely to the efforts of Dr. Brown, his students, and postdoctoral fellows, the use of gene-expression microarrays has become commonplace—a technology recognized as one of the “most powerful tools in modern biology.”10 Dr. Brown’s dedication to the unconditional public release of data, publications, and protocols has played a pivotal role in making this technology accessible to countless labs around the world.
His work has had far-reaching implications and has changed the way we think about problems in human genetics, from a largely reductionist to a holistic perspective. In an interview in 2002, he was quoted as saying “the studies that tend to really have lasting value tend to be the ones where the approach taken at the outset was systematic and the kind of data collected was broader than might have been dictated by a particular narrow question being asked.”11
Dr. Brown’s career and achievements have epitomized that philosophy.
In my opinion, the true mark of the most successful scientist occurs when their invention and their contributions become so commonly accepted that the time prior to their invention becomes quickly forgotten. Such a paradigm shift has occurred with respect to expression analysis and microarray technology in human genetics. Today, we recognize Dr. Pat Brown for his pioneering contributions to this revolution. On behalf of the American Society of Human Genetics and as a member of the Awards Committee, I am privileged to present the 2005 Curt Stern Award to Dr. Patrick O. Brown.
Footnotes
*Previously presented at the annual meeting of The American Society of Human Genetics, in Salt Lake City, on October 29, 2005.
1. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467–470 [PubMed]
2. Smith V, Botstein D, Brown PO (1995) Genetic footprinting: a genomic strategy for determining a gene’s function given its sequence. Proc Natl Acad Sci USA 92:6479–6483 [PubMed] doi: 10.1073/pnas.92.14.6479.
3. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14:457–460 [PubMed] doi: 10.1038/ng1296-457.
4. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96:9212–9217 [PubMed] doi: 10.1073/pnas.96.16.9212.
5. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24:227–235 [PubMed] doi: 10.1038/73432.
6. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283:83–87 [PubMed] doi: 10.1126/science.283.5398.83.
7. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503–511 [PubMed] doi: 10.1038/35000501.
8. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA 100:10623–10628 [PubMed] doi: 10.1073/pnas.1434429100.
9. Diehn JJ, Diehn M, Marmor MF, Brown PO (2005) Differential gene expression in anatomical compartments of the human eye. Genome Biol 6:R74 [PubMed] doi: 10.1186/gb-2005-6-9-r74.
10. Cray D (2001) Gene detective. Time (http://www.cnn.com/SPECIALS/2001/americasbest/science.medicine/pro.pbrown.html) (accessed August 2, 2006).
11. Taubes G (2002) HHMI's Patrick O. Brown on DNA microarrays for the masses. ScienceWatch 13 (http://www.sciencewatch.com/may-june2002/sw_may-june2002_page4.htm) (accessed January 4, 2006).

See more articles cited in this paragraph
See more articles cited in this paragraph